Announcements

Simona Kijonkova’s JSK Investments has participated in a $5 million funding round for UK-based MintNeuro

by
Jakob Ulrych
October 9, 2026
The London-based Imperial College London spin-out develops specialised chips for neural devices, from implants to wearable electronics. The company will use the funding to bring its products to market, expand shipments of pre-production chips to partners and strengthen its presence, particularly in the United States.

The round was led by Odyssey Ventures, with participation from JSK Investments, 33East and Alumni Ventures. Existing investors, including Empirical Ventures and Jumpspace Ventures, also reinvested. The round brings together deep-tech, medtech and early-stage investors from Europe and the United States.

“The main obstacle holding back neurotechnology today is not a lack of ideas, but hardware. MintNeuro is addressing this gap with a platform on which the entire industry can build. We were convinced to invest by its strong technology team, working chips and first long-term commercial contract,”

MintNeuro is already supplying working chips and has achieved key integration milestones with development partners, including Motif Neurotech and Amber Therapeutics. This year, it signed a multi-year agreement with Motif to supply chips for a minimally invasive neurostimulator initially targeting treatment-resistant depression.

A growing number of neural-device manufacturers and research teams are now testing or integrating MintNeuro’s technology. Neural devices are opening up new possibilities for diagnosing and treating neurological and psychiatric conditions, from Parkinson’s disease and epilepsy to depression and hearing loss. However, progress is being constrained by a shortage of chips designed to meet specific requirements for power consumption, size, safety and signal quality.

MintNeuro is therefore developing a modular semiconductor platform for sensing and processing neural signals and delivering targeted electrical stimulation. This enables developers to build smaller, more energy-efficient devices and accelerate their progression from research to clinical use.

“We are delighted to join the JSK portfolio and gain the backing of an investor with a strong network across Europe and the United States, where we are now expanding our operations. With its healthcare connections and experience as both investors and entrepreneurs, our partnership with JSK will help us bring our chips closer to the developers and clinicians shaping the future of neural devices. We also greatly value the experience of JSK’s founders in building a business in international markets, which we can draw on during our next phase of commercial growth,”

MintNeuro was founded as a spin-out from Imperial College London and develops specialised chips for the next generation of neurotechnologies, enabling devices to interface with the brain and nervous system. Its scalable semiconductor platform is designed to accelerate the development of new therapies and neurotechnology products by eliminating the need to develop proprietary chips or adapt general-purpose components.

The company is currently focused primarily on medical applications, with the long-term ambition of becoming the standard chip platform for brain–computer interfaces, bioelectronic medicine and other technologies connecting human biology with the digital world.

“We see neurological conditions affecting people even during their working lives. Neurotechnology has enormous potential to transform the lives of millions of patients, but without cutting-edge hardware, these innovations will remain in the laboratory. MintNeuro is building an essential foundation without which the entire field cannot move forward. That is precisely why the company is such a strong fit for our venture capital investment strategy: its tremendous potential for societal impact, outstanding technology and strong, experienced team,”

JSK Investments SICAV a.s. was established in 2025 as a self-managed investment fund led by Simona Kijonková. It focuses primarily on direct equity investments in Czech and European companies, providing not only capital but also strategic support, entrepreneurial know-how and a hands-on approach.

The fund builds on the previous activities of the JSK Investments family office, founded in 2017 by Czech entrepreneurs and investors Simona and Jaromír Kijonka to grow their family wealth over the long term and support promising companies in their further development.

Subscribe to our newsletter

Join our newsletter to get the best hottest startup tapas.

Popular posts

A record for Czech medtech: Kardi Ai raises €5.3 million to fund global expansion and predictive model development

November 11, 2026

Hedepy secures €4 million from Orbit Capital to fund acquisitions and expand mental health care

November 10, 2026

The humanoid robot race has a new contender: Swiss startup Embodied AI unveils AIR, a humanoid built to work next to factory workers

November 6, 2026

Related posts

Czech medtech startup Kardi Ai has raised €5.3 million in a Series A funding round, marking the largest investment round to date for a Czech medtech startup.
by
Jakob Ulrych
Hedepy, the Czech mental health care platform, has secured €4 million in venture debt financing from Orbit Capital. The company will use the funding primarily for strategic acquisitions and to expand its services, including clinical care and AI-powered tools. Its aim is to consolidate Europe’s fragmented market while continuing to make mental health care accessible to as many people as possible.
by
Jakob Ulrych
The second regional growth equity fund is targeting €150 million with final close expected in 2027.
by
Jakob Ulrych
Engaged Investments, the international venture capital conference organised by investment group DEPO Ventures, brought around 500 investors, founders and tech business leaders from 27 countries to Národní dům in Prague on 21 and 22 October. This year’s edition showed a Central and Eastern European ecosystem that is coming of age. The region has enough capital, AI is speeding up product development, and more and more founders are coming back as investors. Data presented at the conference also showed a gap. While record capital is flowing into hard technologies across the region, Czech startups in this segment have not raised a single crown from venture investors this year.
by
Jakob Ulrych